Levels of engraftment in serial NOD/SCID transplants
Patient no. . | No. of cells injected . | % CD45+ . | ||
---|---|---|---|---|
Primary . | Secondary . | Tertiary . | ||
2 | 1× 107 | 99.0 ± 0.3 | 95.0 ± 2.0 | 99.0 ± 0.4 |
6 | 1 × 107 | 98.0 ± 2.0 | 91.0 ± 8.0 | 83.0 ± 0.7 |
12 | 1 × 106 | 60.0 ± 8.0 | 47.0 ± 13.0 | 37.0 ± 5.0 |
13 | 5 × 106 | 38.0 ± 10.0 | 48.0 ± 4.0 | — |
14 | 1 × 107 | 79.0 ± 6.0 | 63.0 ± 11.0 | — |
16 | 5 × 106 | 26.0 ± 3.0 | 18.0 ± 7.0 | — |
Patient no. . | No. of cells injected . | % CD45+ . | ||
---|---|---|---|---|
Primary . | Secondary . | Tertiary . | ||
2 | 1× 107 | 99.0 ± 0.3 | 95.0 ± 2.0 | 99.0 ± 0.4 |
6 | 1 × 107 | 98.0 ± 2.0 | 91.0 ± 8.0 | 83.0 ± 0.7 |
12 | 1 × 106 | 60.0 ± 8.0 | 47.0 ± 13.0 | 37.0 ± 5.0 |
13 | 5 × 106 | 38.0 ± 10.0 | 48.0 ± 4.0 | — |
14 | 1 × 107 | 79.0 ± 6.0 | 63.0 ± 11.0 | — |
16 | 5 × 106 | 26.0 ± 3.0 | 18.0 ± 7.0 | — |
— indicates not tested.